1 Medizinische Klinik und Poliklinik D, Experimentelle Nephrologie, and 2 Klinik und Poliklinik für Kinderheilkunde, Universitätsklinikum Münster, D-48149 Münster; and 3 Institut für Anatomie und Zellbiologie, Universität Würzburg, D-97070 Würzburg, Germany
![]() |
ABSTRACT |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Properties and regulation of the human organic cation (OC) transporter type 2 (hOCT2) expressed in HEK-293 cells were extensively characterized using the fluorescent OC 4-[4-(dimethylamino)styryl]-N-methylpyridinium (ASP+). ASP+ uptake was electrogenic and inhibited by TPA+ (EC50 = 2.7 µM), tetraethylammonium (EC50 = 35 µM), cimetidine (EC50 = 36 µM), or quinine (EC50 = 6.7 µM). Stimulation with carbachol or ATP decreased initial uptake by 44 ± 3 (n = 14) and 34 ± 4% (n = 21), respectively, independently of PKC but dependent on phosphatidylinositol 3-kinase (PI3K). PKA stimulation decreased uptake by 18 ± 4% (n = 40). Inhibition of calmodulin (CaM), Ca2+/CaM-dependent kinase II, or myosin light chain kinase decreased uptake by 63 ± 2 (n = 15), 40 ± 4 (n = 30), and 31 ± 4% (n = 16), respectively. Inhibition of CaM resulted in a significant change in the EC50 value for the inhibition of ASP+ uptake by tetraethylammonium. In conclusion, we demonstrate that the hOCT2 is inhibited by PI3K and PKA and activated by a CaM-dependent signaling pathway, probably via a change in substrate affinity.
organic cation transport; human organic cation transporter type 2; human; calcium/calmodulin; calcium/calmodulin-dependent kinase II; myosin light chain kinase; phospholipase C; protein kinase C; protein kinase A; phosphatidylinositol 3-kinase; electrophysiology; fluorescence microscopy; 4-[4-(dimethylamino)styryl]-N-methylpyridinium
![]() |
INTRODUCTION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
THE TERM ORGANIC CATIONS REFERS to a broad class of compounds of endogenous (e.g., choline, N1-methyl-nicotineamide, monoamine neurotransmitters such as dopamine and noradrenaline) and exogenous (e.g., cytostatics, antibiotics, opiates, antihypertensives, antiarrythmics, antihistamines, and sedatives) origin. The kidney is one of the most important organs in maintaining the homeostasis of organic cations (16, 17, 46). Besides substrate-specific, Na+-dependent organic cation transporters, Na+-independent polyspecific organic cation transporters (OCTs) have been postulated for the epithelia in the intestine, liver, kidney, and also for the brain (15-17, 46).
In 1994, the first organic cation transporter from the rat (rOCT1) was cloned by expression cloning (6). rOCT1 was shown to be the electrogenic organic cation transporter in the basolateral plasma membrane of kidney and liver (2, 6, 14, 21, 34). The successive identification of several OCTs of different species by homology cloning techniques (5) allowed (15-17, 19, 24, 36, 46-48) the investigation of molecular and physiological properties of single OCTs. A common feature of the OCTs is the presence of several potential protein kinase phosphorylation sites in the intracellular loops, suggesting that their activity can be subjected to regulation. We could indeed show that activation of PKC with subsequent phosphorylation of a serine residue of rOCT1 resulted in a stimulation of organic cation transport with an increase in substrate affinity and that rOCT1-mediated organic cation transport was also activated by PKA and endogenously stimulated by tyrosine kinases (21). Whereas rOCT1 is the principal OCT in the rat kidney, hOCT2 has been suggested to be the most important one in the human kidney (5). The more sensitive RT-PCR analysis showed additional transcription of hOCT2 mRNA in intestine, brain, spleen, and placenta (5). We also localized hOCT2 by RT-PCR in human isolated proximal tubules, and our functional studies with this preparation showed that hOCT2 is localized in the basolateral membrane (25). These results were recently confirmed by real-time PCR and immunohistochemical analysis of the human proximal tubule (22).
Functional characterization of hOCT2 expressed in HEK-293 cells or Xenopus laevis oocytes with tracer flux measurements and patch-clamp studies showed that hOCT2, like other transporters of the OCT type (OCT1, OCT2 and OCT3), mediates electrogenic transport of small organic cations such as choline, tetraethylammonium (TEA+), N1-methyl-nicotineamide (NMN+), and 1-methyl-4-phenylpyridinium (MPP+). hOCT2 and other OCT-type transporters differ in their substrate specifities and affinities (1, 5, 15, 17, 46).
Regulation of organic cation transport is important for the secretion of multiple cationic endogenous substances, drugs, and other xenobiotics and might explain the differences reported so far in substrate affinities and differences in pharmacokinetics of organic cations. To date, only a few studies have addressed the regulation of organic cation transport and none that of hOCT2. Regulation of the human extraneuronal monoamine transporter hEMT (also named hOCT3) by phosphorylation/dephosphorylation mechanisms was recently shown (20). hEMT was inactivated by phosphorylation, especially by inhibition of MAP kinases, Ca2+/calmodulin (CaM), phosphodiesterases, or protein phosphatases.
The purpose of the present study was to investigate the properties of hOCT2 expressed in HEK-293 cells, with special emphasis on its regulation by protein kinases.
![]() |
METHODS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
HEK-293 cell culture. hOCT2 was stably expressed in HEK-293 cells (human embryonic kidney cortex cells, CRL-1573; American Type Culture Collection, Rockville, MD). Cells were grown at 37°C in 50-ml cell culture flasks (Greiner, Frickenhausen, Germany) in Dulbecco's modified Eagle's medium (Biochrom, Berlin, Germany) containing 3.7 g/l NaHCO3, 1.0 g/l D-glucose, and 2 mM L-glutamine (GIBCO BRL/Life Technologies, Eggenstein, Germany) gassed with 8% CO2. To this medium, 100,000 U/l penicillin, 100 mg/l streptomycin (Biochrom), 10% fetal calf serum, and 0.8 mg/ml geneticin (GIBCO BRL/Life Technologies) were added. Experiments were performed after 4-8 days with cells grown on glass coverslips from passages 11-42. Culture and functional analysis of these cells were approved by the Landesumweltamt Nordrhein-Westfalen, Essen, Germany (521.-M-1.14/00).
Experimental solutions.
As the superfusion solution, a HCO
Fluorescence measurements with 4-[4-(dimethylamino)styryl]-N-methylpyridinium. As a substrate for hOCT2, the fluorescent organic cation 4-[4-(dimethylamino)styryl]-N-methylpyridinium (ASP+) was used (26, 29, 39). The fluorescence measurement device and experimental procedure were as customary in our laboratory (13, 21, 32, 33). In short, measurements were performed in the dark with an inverted microscope (Axiovert 135, Zeiss, Oberkochen, Germany) equipped with a ×100 oil-immersion objective. Cells were excited pulsatory at 450-490 nm, and emission was measured at 575-640 nm with a photon-counting tube (Hamamatsu H 3460-04, Herrsching, Germany).
After addition of ASP+, fluorescence increased rapidly due to cellular accumulation of ASP+ via hOCT2 (Fig. 1). As transport parameters, we evaluated the initial linear slope of the first 10-30 s (Fig. 1). In the initial experiments examining the concentration dependence of an ASP+-induced fluorescence increase, we analyzed in addition the maximal fluorescence reached. While the initial slope directly represents the ASP+ uptake across the plasma membrane via hOCT2, the maximal fluorescence is the sum of ASP+ uptake into the cells, exit of ASP+ from the cells, intracellular compartmentalization with changes in the emission spectrum, and bleaching of the dye (21, 25, 32, 33). In all experiments with other substrates and regulators, only the initial slope of the curves was determined as a transport parameter. To study regulation of ASP+ uptake, monolayers were incubated for 10 min with the respective agonists or inhibitors before ASP+ was added in the continued presence of these substances.
|
Fluorescence measurements with fura 2. Intracellular Ca2+ concentrations ([Ca2+]i) of HEK-293 cells were measured with the Ca2+-sensitive dye fura 2, as described previously (31). Cells were incubated with the acetomethyl ester (fura 2-AM; 5 µM) dissolved with 0.1 g/l pluronic F-127 in standard solution for 40 min at 37°C in the dark. Measurements were done with the same fluorescence system as described above (excitation: 340, 360, and 380 nm; emission: 500-530 nm). The ratio of the emissions after excitations at 340 and 380 nm was calculated. Calibration of [Ca2+]i was done by incubating the cells with the Ca2+ ionophore ionomycin (1 µM) in the presence (1.3 mmol/l) and nominal absence of Ca2+ with 5 mM EGTA present, according to standard methods (8).
Patch-clamp experiments.
Membrane voltages (Vm) were measured with the
slow whole cell patch-clamp technique as performed before for rOCT1
(21). Pipettes were filled with a solution containing (in
mM) 95 K+ gluconate, 30 KCl, 4.8 Na2HPO4, 1.2 NaH2PO4, 5 D-glucose, 0.73 Ca2+ gluconate, 1 EGTA, 1.03 MgCl2, and 1 ATP, pH adjusted to 7.2. To this solution, 162 µM nystatin was added before use to permeabilize the membrane patch
under the pipette. Patch pipettes had an input resistance of ~10
M. Vm was measured in the current-clamp mode of a patch-clamp amplifier (U. Fröbe, Physiologisches Institut, Universität Freiburg, Freiburg, Germany).
Chemicals.
BAPTA, forskolin, sn-1,2-dioctanoyl glycerol (DOG),
calphostin C,
1-[N,O-bis-(5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenylpiperazine (KN-62),
2-[N-(4-methoxybenzenesulfonyl)]amino-N-(4-chlorocinnamyl)-N- methylbenzylamine
phosphate (KN-92), calmidazolium,
1-(5-iodonapthalene-1-sulfonyl)homopiperazine (ML-7),
[1,4- diamino-2,3-dicyano-1,4-bis(2-aminophenylthio)butadiene] (UO126),
{1-[6-((17-3-methoxyestra-1,3,5(10)-trien-17-yl)- amino)hexyl]-2,5-pyrrolidinedione} (U-73122), wortmannin, and pluronic were purchased from Calbiochem (Bad
Soden, Germany). Human atrial natriuretic peptide was kindly provided by Dr. Knut Adermann (Niedersächsisches Institut
für Peptid-Forschung, Hannover, Germany). ASP+ was
purchased from Molecular Probes (Leiden, The Netherlands). All other
substances and standard chemicals were obtained from Sigma
(Taufkirchen, Germany) or Merck (Darmstadt, Germany).
Statistical analysis. Data are presented as originals or means ± SE, with n referring to the number of monolayers (fluorescence measurements) or cells (patch-clamp experiments). EC50 values were obtained by sigmoidal curve fittings (GraphPad InStat, San Diego, CA). Unpaired (fluorescence measurements) or paired (patch-clamp experiments) two-tailed Student's t-test was used to prove statistical significance of the effects. Entire concentration-response curves were compared using an F-test. A P value <0.05 was considered statistifically significant.
![]() |
RESULTS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Concentration dependence of ASP+ uptake. First, we determined the concentration dependence of ASP+ uptake by HEK-293 cells via hOCT2. At ASP+ concentrations between 0.1 µM and 1 mM, the cellular fluorescence increased concentration dependently (Fig. 1). Saturation of the fluorescence signal was only reached for the maximal fluorescence but not for the initial rate. Concentrations of ASP+ higher than 1 mM could not be dissolved in aqueous solutions. Because 1 µM ASP+ already resulted in a significant cellular fluorescence increase (Fig. 1), all further fluorescence experiments were performed with this ASP+ concentration. Figure 1 also demonstrates that ASP+ uptake was mediated by hOCT2 because the nontransfected HEK-293 cells showed only a very small and slow fluorescence increase with time.
Substrate specificity.
Next, we investigated the substrate specificity of hOCT2 by studying
inhibition of ASP+ uptake by known substrates of organic
cation transport, like TEA+, TPA+, and
cimetidine, and by the inhibitor of organic cation transporters, quinine (23). TPA+, TEA+, and
cimetidine inhibited ASP+ uptake concentration dependently,
with EC50 values of 2.7, 35, and 36 µM, respectively
(Fig. 2). ASP+ uptake was
also concentration dependently inhibited by quinine, with an
EC50 value of 6.7 µM (Fig. 2).
|
Electrogeneity of ASP+ uptake.
Previous investigations showed the electrogeneity of hOCT2
(5), a known feature of the OCT-type transporters
(2, 6, 15, 21, 46). We confirmed this property of hOCT2 in
two ways. First, we measured the cellular fluorescence increase via hOCT2 by raising the K+ concentration in the superfusion
solution from 3.6 to 50 and 145 mM. Under these conditions, the
membrane voltage of transfected HEK-293 cells depolarized from
44 ± 2 to
17 ± 1 and to +6 ± 1 mV
(n = 6) (21). Initial ASP+
uptake was inhibited by 22 ± 8 (n = 8) and
55 ± 4% (n = 9), respectively (Fig. 3,
left). Second, we proved the
electrogeneity of hOCT2 by determining the dependence of membrane
depolarization on the ASP+ concentration in the bath with
the slow whole cell patch-clamp technique. Increasing ASP+
concentrations from 1 µM to 1 mM resulted in increasing membrane depolarizations (Fig. 3, right).
|
Regulation by PLC and PKC.
To investigate the involvement of the PLC and the subsequent PKC
signaling pathway in the regulation of hOCT2, we tested different agonists. Incubation of cells with the muscarinic agonist carbachol resulted in a concentration-dependent inhibition of ASP+
uptake at concentrations between 0.1 and 100 µM (Fig.
4). Maximal inhibition at 100 µM
carbachol was 44 ± 3% (n = 14). Without
incubation, this carbachol concentration had no significant effect on
ASP+ uptake (n = 10), indicating that the
positively charged carbachol did not interfere significantly with hOCT2
as substrate.
|
|
Regulation by PKA. To investigate the involvement of the cAMP-dependent protein kinase (PKA) in the regulation of organic cation transport via hOCT2, we used the adenylate cyclase activator forskolin. Compared with carbachol or ATP, forskolin had a weaker concentration-dependent effect on ASP+ uptake (Fig. 4). At 1 µM forskolin, ASP+ uptake was significantly reduced by 18 ± 4% (n = 40).
Regulation by Ca2+ and the
Ca2+/CaM complex.
Because activation of G protein-coupled receptors by carbachol or ATP
reduced ASP+ uptake most likely independently of PKC, we
further investigated whether this effect involves an increase in
cytosolic Ca2+ and the Ca2+/CaM complex. To
verify an increase in [Ca2+]i after carbachol
or ATP in HEK-293 cells and to estimate its magnitude, Ca2+
measurements with fura 2 were conducted. Carbachol (100 µM) and ATP
(100 µM) increased [Ca2+]i by 300 ± 40 (n = 5) and 420 ± 62 nM (n = 5), respectively; therefore, the role of
[Ca2+]i in the regulation of hOCT2 was
examined. Reduction of the extracellular Ca2+ concentration
from 1.3 mM to 1 µM Ca2+ resulted in an inhibition of
ASP+ transport by 50 ± 5% (n = 16)
(Fig. 6). Reduction of
[Ca2+]i by incubation of cells with the
Ca2+ chelator BAPTA (5 µM) led to a reduction in
ASP+ uptake by 41 ± 5% (n = 15)
(Fig. 6). The incubation of cells with carbachol in the presence of
BAPTA resulted in a significantly, even larger, reduction in
ASP+ uptake compared with either carbachol or BAPTA alone,
indicating an independence of the carbachol effect of
[Ca2+]i (Fig. 6).
|
|
|
Regulation by the phosphatidylinositol 3-kinase.
Because activation of G protein-coupled receptors can also stimulate
phosphatidylinositol 3-kinase (PI3K), we tested whether the effect of
carbachol is influenced by inhibition of PI3K. Incubation with the PI3K
inhibitor wortmannin (0.1 µM) alone significantly stimulated basal
transport activity of HEK-293 cells (55 ± 17%, n = 16) (Fig. 7), indicating endogenous activation of this enzyme. Pretreatment of the cells with wortmannin could almost completely prevent the effect of simultaneous incubation with carbachol (100 µM)
on initial ASP+ uptake (7 ± 5%, n = 11) (Fig. 7). Further downstream in the signaling cascade are also
the mitogen-activated kinase kinases MEK1 and MEK2. Inhibition of these
kinases by UO126 (1 µM) had no effect on basal ASP+
transport (
4 ± 12%, n = 6) or on
carbachol-induced inhibition of ASP+ uptake (
42 ± 4%, n = 6).
Influence of protein kinase activation on substrate affinities.
For the OCT1 of rat (rOCT1), we reported that PKC activation results in
a modulation of the affinities for various substrates (21). To examine whether inhibition of the hOCT2 by
blocking the Ca2+/CaM complex or by carbachol also results
in altered substrate affinities, EC50 values for
TEA+ were determined under these conditions and compared
with those obtained under control conditions. Activation of the G
protein-coupled receptor signaling pathways by carbachol (100 µM) or
inhibition of the CaMKII by KN-62 or of PI3K by wortmannin induced no
significant changes in the concentration-response curves for the
inhibition of ASP+ uptake by TEA+ (Fig.
9). Conversely, inhibition of CaM by the
CaM antagonist calmidazolium (5 µM) significantly reduced the
apparent affinity of hOCT2 for TEA+ (EC50 = 249 µM) compared with 35 µM under basal conditions.
|
![]() |
DISCUSSION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Organic cation transport in epithelia is mediated by several polyspecific transporters, which initially have been examined functionally using different experimental models and techniques (15-17, 46). In the renal proximal tubule, three main transport systems for organic cations were functionally differentiated: a basolaterally localized electrogenic uniporter, a luminally localized electroneutral H+/cation exchanger, and a luminally localized electrogenic uniporter with high affinity to choline (17). The cloning of the first organic cation transporter from the rat (rOCT1) in 1994 (6) made it possible to specifically characterize single organic cation transporters after stable transfection in different cell models (15, 16, 21, 46). Functional and morphological studies suggested that the transporters of the OCT type are polyspecific organic cation transporters localized in the basolateral membrane (2, 6, 14, 21, 23, 34). In 1997, the first human organic cation transporters were cloned (5, 7, 35, 43, 47).
In this study, we investigated the properties and regulation of hOCT2 stably transfected in a human embryonic kidney cell line (HEK-293). Dynamic microfluorimetry with the fluorescent organic cation ASP+, as adapted in our laboratory (13, 21, 25, 32, 33), and the slow whole cell patch-clamp technique were used. We confirm the electrogeneity of this transporter and describe its substrate specificity for some classic organic cations. Most importantly, we demonstrate for the first time that hOCT2 is regulated by various intracellular signaling pathways. It is inhibited by PKA, PLC, and PI3K activation but not by PKC activation. It is endogenously activated by the Ca2+/CaM complex and the Ca2+/CaM-dependent kinases CaMKII and MLCK.
The fluorescent organic cation ASP+ is taken up concentration dependently via hOCT2. However, as shown before for rOCT1 (21), the initial rate of cellular ASP+ accumulation did not reach saturation in the range of concentrations used. As discussed before (33), this may indicate that at higher concentrations ASP+ is accumulated in intracellular compartments. While the initial slope of the uptake, analyzed during the first 10-30 s, directly represented ASP+ uptake across the plasma membrane of HEK-293 cells, the fluorescence maximum reflected a steady state of ASP+ uptake into the cells, ASP+ transport out of the cells, intracellular compartmentalization, and bleaching of the dye (21, 25). Therefore, transport was analyzed as the initial rate of fluorescence increase, using low concentrations of ASP+ (1 µM). As shown in Fig. 1, initial uptake of ASP+ by these transfected HEK-293 cells was mediated by hOCT2 only.
Substrate specificity. Previous radioactive tracer or electrophysiological studies on hOCT2 expressed in HEK-293 cells or X. laevis oocytes showed that hOCT2 transports small organic cations, such as TEA+, TPA+, NMN+, and choline, and is noncompetitively inhibited by larger organic cations, such as quinine, d-tubocurarine, and vecuronium (15-17, 42, 46). The EC50 values obtained for the inhibition of ASP+ uptake in the present study by TEA+ (EC50 = 35 µM), TPA+ (EC50 = 2.7 µM), cimetidine (EC50 = 36 µM), and quinine (EC50 = 6.7 µM) are similar to Km or Ki values determined with radiolabeled substrates for hOCT2 expressed in X. laevis oocytes: Km for radiolabeled TEA+ was 76 µM, and Ki for the inhibition of radiolabeled TEA+ uptake by TPA+ or quinine were 1.5 and 3.4 µM, respectively (5).
Electrogeneity of hOCT2. A common feature of all OCT-type transporters is their electrogeneity (15-17, 46). In the present study, we confirmed this electrogeneity in two ways: 1) in microfluorimetric studies, ASP+ uptake was dependent on membrane voltage and decreased with membrane depolarization induced by increases in extracellular K+ concentration (Fig. 3); and 2) in electrophysiological studies, increasing ASP+ concentrations led to increasing depolarization of the membrane voltage of transfected HEK-293 cells due to the influx of positive charges. While the first finding could also be due to changes in substrate binding, the second clearly indicates electrogenic transport.
Regulation of hOCT2. The regulation of organic cation transport has been under investigation only recently (13, 21, 25). Organic cation transport across the basolateral membrane of proximal tubules was activated in rabbits (12) and inhibited in humans (25) by PKC stimulation. An increase in transport mediated by the rOCT1 was shown by us for PKC and PKA and the tyrosine kinase p56lck (21). Similar differences in regulation were also demonstrated by us for organic cation transport across the apical membrane of human and porcine proximal tubule cell lines (13). These findings suggest species- and also subtype-specific differences in transporter regulation. For OCT2 as well as for OCT1 transporters from rats and humans, several potential phosphorylation sites for PKA, PKC, and tyrosine kinases were described; some of them are conserved through all four isoforms (5, 6).
cAMP-dependent PKA. Addition of the adenylate cyclase activator forskolin leading to activation of PKA resulted in a small concentration-dependent inhibition of ASP+ uptake via hOCT2. Recently, we demonstrated that in freshly isolated human proximal tubules organic cation transport across the basolateral membrane, probably mainly mediated via hOCT2, is also downregulated by PKA to a similar extent (25). hEMT (hOCT3) again expressed in HEK-293 cells showed no cAMP-dependent regulation, and only nonspecific high concentrations of forskolin (250 µM) led to a small reduction in radiolabeled MPP+ transport in that study (20).
G protein-coupled receptor and PKC. To investigate the effect of activation of G protein-coupled receptor on ASP+ uptake in hOCT2-transfected HEK-293 cells, we used the purinergic agonist ATP and the muscarinic agonist carbachol. Receptors for both agonists have been demonstrated in HEK-293 cells (27, 37). ATP and carbachol resulted in inhibition of ASP+ uptake by ~34 and 44%, respectively. We excluded the involvement of PKC in this effect by using the direct PKC activator DOG, a membrane-permeable analog of diacylglycerol. DOG had no significant effect on hOCT2-mediated ASP+ uptake. The fact that PKC was not involved in the effect of carbachol was further verified by simultaneous incubation of the cells with carbachol and the PKC inhibitors calphostin C or tamoxifen. Neither PKC inhibitor significantly influenced the carbachol-induced inhibition of ASP+ transport. This absence of a PKC-mediated regulation of hOCT2, therefore, parallels similar observations for hOCT3 (20) but is in contrast to the PKC-mediated activation of rOCT1 (21) or organic cation transport across the basolateral membrane of isolated rabbit proximal tubules (PKC-mediated activation) (12) or isolated human proximal tubules (PKC-mediated inhibition) (25). These findings also underline the marked differences in transport properties of these organic cation transporters between the different species and, possibly, the expression systems. Furthermore, it should be kept in mind that for hOCT1 and hOCT2 various splice variants were identified and that, especially in the human proximal tubule, expression of a splice variant to the originally cloned hOCT2 as the relevant transporter was described recently (11, 40).
CaM and Ca2+/CaM-dependent kinases.
After exclusion of PKC involvement in the regulation of hOCT2, we
further investigated whether CaM and CaMKII or MLCK is involved in the
regulation of hOCT2-mediated ASP+ uptake. Inhibition of CaM
with calmidazolium resulted in a marked reduction in hOCT2 transport by
63%, indicating an endogenous activation of the Ca2+/CaM
pathway. In line with this effect of CaM inhibition is the reduced
activity of hOCT2 when cellular Ca2+ was decreased by using
the Ca2+ chelator BAPTA or by lowering extracellular
Ca2+ to 1 µM, which also leads to reduction in cellular
Ca2+ levels. Activation of CaM by Ca2+
stimulates the multifunctional CaMKII, which is known to phosphorylate many target proteins, leading to changes in their activity.
Consequently, also an inhibition of CaMKII by KN-62 reduced
hOCT2-mediated ASP+ transport by 40%. We verified the
specificity of this inhibition by KN-62 with the inactive analog KN-92,
which was without a significant effect. Because KN-62 inhibits not only
CaMKII but also CaMKIV and CaMKV with similar affinities, these kinases
may be involved in the observed effects as well. In addition to CaMKII,
MLCK is also activated by CaM. Inhibition of MLCK by ML-7 reduced
ASP+ uptake via hOCT2 again by 31%. Together these data
indicate that hOCT2 is endogenously activated via CaM-dependent CaMKII
and MLCK stimulation. A similar regulation was shown for the renal
basolateral PAH transporter by CaMKII in isolated proximal tubules of
the rabbit (3). The involvement of CaMKII was also
demonstrated for the regulation of the Na+/H+
exchanger (41), the Na+-HCO
PI3K.
Stimulation of G protein-coupled receptors mediates intracellular
signaling via GTP-bound G protein -subunits or
-complexes. The
GTP-bound G protein
-subunits initiate the classic cascade involving
diacylglycerol and inositol 3,4,5-trisphosphate, whereas the
-complexes activate a cascade that connects G receptor activation to PI3K and the subsequent MAPK signaling pathway (9, 10). We have therefore tested whether the signal pathway mediated by
-complexes is involved in the regulation of hOCT2 by carbachol. The incubation of the cells with wortmannin, a potent inhibitor of PI3K
activity, significantly stimulated the ASP+ uptake via
hOCT2, showing that the enzyme is endogenously activated. Stimulation
of the G protein-coupled receptor by carbachol and the contemporaneous
inhibition of the PI3K activity by wortmannin almost completely
prevented the reduction of initial ASP+ uptake of HEK-293
cells. The involvement of PI3K was also demonstrated for the regulation
of renal organic anion transporter and of P-glycoprotein-mediated drug
efflux. Wortmannin was able to inhibit tubular basolateral transport of
PAH in isolated proximal tubules from rabbit kidney (4)
and to inhibit apical P-glycoprotein-mediated drug efflux in the
proximal tubule of mice (38). The involvement of G
receptor-linked stimulation of MAPK activity was also demonstrated for
the regulation of Na-HCO
TEA+ affinity and hOCT2 regulation. Recently, we demonstrated the increase in affinity for the organic cation transporter rOCT1 by PKC-dependent phoshorylation (21). To find out whether the affinities of hOCT2 were also changed when transport is downregulated, e.g., by activation of the G protein-coupled receptor pathway, or by CaM or CaMKII inhibition, we determined concentration-response curves for TEA+, when cells were incubated with carbachol, calmidazolium, KN-62, or wortmannin. Only incubation with calmidazolium resulted in a significant change in the concentration-response curves for the inhibition of ASP+ uptake by TEA+ (Fig. 9). This is further evidence for the independence of the carbachol effect on transport activity from the CaM pathway. The absence of an effect of KN-62 on the EC50 value for TEA+ could be explained by assuming that CaM acts directly on the transporter or by the fact that inhibition by KN-62 is too low to detect changes in the EC50 value in this system. These findings, together with the finding that contemporaneous incubation with carbachol and wortmannin almost completely prevented the reduction of initial ASP+ uptake observed with carbachol alone, suggest that the PI3K signaling pathway can be directly involved in the regulation of hOCT2 after stimulation of the G protein-coupled receptor.
In conclusion, we have shown that several signaling pathways are involved in the regulation of hOCT2-mediated organic cation transport. Whereas PKA stimulation resulted in inhibition, endogenously active CaM or the CaM-dependent kinases CaMKII and MLCK led to activation, and inhibition of this pathway led to a reduction, of hOCT2-mediated transport. Activation of PKC had no effect on this transporter. Activation of the G receptor-coupled signaling pathway by carbachol inhibited hOCT2-mediated transport, probably acting through PI3K. Regulation of organic cation transporters may alter the secretion and absorption of multiple endogenous substances, drugs, and other xenobiotics, leading to changes in pharmacokinetics of these organic cations. ![]() |
ACKNOWLEDGEMENTS |
---|
We thank Ute Kleffner, Ingrid Kleta and Ulrich Siegel for technical assistance.
![]() |
FOOTNOTES |
---|
This work was supported by the Deutsche Forschungsgemeinschaft (Schl 277/8-1).
Address for reprint requests and other correspondence: E. Schlatter Universitätsklinikum Münster Medizinische Klinik und Poliklinik D Experimentelle Nephrologie, Domagkstrasse 3a, D-48149 Münster, Germany (E-mail: eberhard.schlatter{at}uni-muenster.de).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
First published October 15, 2002;10.1152/ajprenal.00251.2002
Received 11 June 2002; accepted in final form 9 October 2002.
![]() |
REFERENCES |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
1.
Busch, AE,
Karbach U,
Miska D,
Gorboulev V,
Akhoundova A,
Volk C,
Arndt P,
Ulzheimer JC,
Sonders MS,
Baumann C,
Waldegger S,
Lang F,
and
Koepsell H.
Human neurons express the polyspecific cation tranporter hOCT2, which translocates monoamine neurotransmitters, amantadine, and memantine.
Mol Physiol
54:
342-352,
1998.
2.
Busch, AE,
Quester S,
Ulzheimer JC,
Waldegger S,
Gorboulev V,
Arndt P,
Lang F,
and
Koepsell H.
Electrogenic properties and substrate specificity of the polyspecific rat cation transporter rOCT1.
J Biol Chem
271:
32599-32604,
1996
3.
Gabriëls, G,
Krämer C,
Stärk U,
and
Greven J.
Role of the calcium/calmodulin-dependent protein kinase II in the regulation of the renal basolateral PAH and dicarboxylate transporters.
Fundam Clin Pharmacol
13:
59-66,
1999[ISI][Medline].
4.
Gabriëls, G,
Werners A,
Mauss S,
and
Greven J.
Evidence for differential regulation of renal proximal tubular p-aminohippurate and sodium-dependent dicarboxylate transport.
J Pharmacol Exp Ther
290:
710-715,
1999
5.
Gorboulev, V,
Ulzheimer JC,
Akhoundova A,
Ulzheimer-Teuber I,
Karbach U,
Quester S,
Baumann C,
Lang F,
Busch AE,
and
Koepsell H.
Cloning and characterization of two human polyspecific organic cation transporters.
DNA Cell Biol
16:
871-881,
1997[ISI][Medline].
6.
Gründemann, D,
Gorboulev V,
Gambaryan S,
Veyhl M,
and
Koepsell H.
Drug excretion mediated by a new prototype of polyspecific transporter.
Nature
372:
549-552,
1994[ISI][Medline].
7.
Gründemann, D,
Schechinger B,
Rappold GA,
and
Schömig E.
Molecular identification of the corticosterone-sensitive extraneuronal catecholamine transporter.
Nat Neurosci
1:
349-351,
1998[ISI][Medline].
8.
Grynkiewicz, G,
Poenie M,
and
Tsien RY.
A new generation of Ca2+ indicators with greatly improved fluorescence properties.
J Biol Chem
260:
3440-3450,
1985[Abstract].
9.
Gutkind, JS.
The pathways connecting G protein-coupled receptors to the nucleus through divergent mitogen-activated protein kinase cascades.
J Biol Chem
273:
1839-1842,
1998
10.
Hawes, BE,
Luttrell LM,
Van Biesen T,
and
Lefkowitz RJ.
Phosphatidylinositol 3-kinase is an early intermediate in the G beta gamma-mediated mitogen-activated protein kinase signaling pathway.
J Biol Chem
271:
12133-12136,
1996
11.
Hayer, M,
Bonisch H,
and
Bruss M.
Molecular cloning, functional characterization and genomic organization of four alternatively spliced isoforms of the human organic cation transporter 1 (hOCT1/SLC22A1).
Ann Hum Genet
63:
473-482,
1999[ISI][Medline].
12.
Hohage, H,
Mörth DM,
Querl IU,
and
Greven J.
Regulation by protein kinase C of the contraluminal transport system for organic cations in rabbit kidney S2 proximal tubules.
J Pharmacol Exp Ther
268:
897-901,
1994[Abstract].
13.
Hohage, H,
Stachon A,
Feidt C,
Hirsch JR,
and
Schlatter E.
Regulation of organic cation transport in IHKE-1 and LLC-PK1 cells. Fluorimetric studies with 4-(4-dimethylaminostyryl)-N-methylpyridinium.
J Pharmacol Exp Ther
286:
305-310,
1998
14.
Karbach, U,
Kricke J,
Meyer-Wentrup F,
Gorboulev V,
Volk C,
Loffing-Cueni D,
Kaissling B,
Bachmann S,
and
Koepsell H.
Localization of organic cation transporters OCT1 and OCT2 in rat kidney.
Am J Physiol Renal Physiol
279:
F679-F687,
2000
15.
Koepsell, H.
Organic cation transporters in intestine, kidney, liver, and brain.
Annu Rev Physiol
60:
243-266,
1998[ISI][Medline].
16.
Koepsell, H,
Busch AE,
Gorboulev V,
and
Arndt P.
Structure and function of renal organic cation transporters.
News Physiol Sci
13:
11-16,
1998
17.
Koepsell, H,
Gorboulev V,
and
Arndt P.
Molecular pharmacology of organic cation transporters in kidney.
J Membr Biol
167:
103-117,
1999[ISI][Medline].
18.
Koh, SD,
Jun JY,
Kim TW,
and
Sanders KM.
A Ca2+-inhibited non-selective cation conductance contributes to pacemaker currents in mouse interstitial cell of Cajal.
J Physiol
540:
803-814,
2002
19.
Lopez-Nieto, CE,
You G,
Bush KT,
Baros EJ,
Beier DR,
and
Nigam SK.
Molecular cloning and characterization of NKT, a gene product related to the organic cation transporter family that is almost exclusively expressed in the kidney.
J Biol Chem
272:
6471-6478,
1997
20.
Martel, F,
Keating E,
Calhau C,
Gründemann D,
Schömig E,
and
Azevedo I.
Regulation of human extraneuronal monoamine transporter (hEMT) expressed in HEK293 cells by intracellular second messenger systems.
Naunyn Schmiedebergs Arch Pharmacol
364:
487-495,
2001[ISI][Medline].
21.
Mehrens, T,
Lelleck S,
Çetinkaya I,
Knollmann M,
Hohage H,
Gorboulev V,
Bokník P,
Koepsell H,
and
Schlatter E.
The affinity of the organic cation transporter rOCT1 is increased by protein kinase C dependent phosphorylation.
J Am Soc Nephrol
11:
1216-1224,
2000
22.
Motohashi, H,
Sajurai Y,
Saito H,
Masuda S,
Urakami Y,
Goto M,
Fukuda S,
Ogawa O,
and
Inui KI.
Gene expression levels and immunolocalization of organic ion transporters in the human kidney.
J Am Soc Nephrol
13:
866-874,
2002
23.
Nagel, G,
Volk C,
Friedrich T,
Ulzheimer JC,
Bamberg E,
and
Koepsell H.
A reevaluation of substrate specificity of the rat cation transporter rOCT1.
J Biol Chem
272:
31953-31956,
1997
24.
Okuda, M,
Saito H,
Urakami Y,
Takano M,
and
Inui K.
cDNA cloning and functional expression of a novel rat kidney organic cation transporter, OCT2.
Biochem Biophys Res Commun
224:
500-507,
1996[ISI][Medline].
25.
Pietig, G,
Mehrens T,
Hirsch JR,
Çetinkaya I,
Piechota H,
and
Schlatter E.
Properties and regulation of organic cation transport in freshly isolated human proximal tubules.
J Biol Chem
276:
33741-33746,
2001
26.
Pietruck, F,
and
Ullrich KJ.
Transport interactions of different organic cations during their excretion by the intact rat kidney.
Kidney Int
47:
1647-1657,
1995[ISI][Medline].
27.
Qi, Z,
Murase K,
Obata S,
and
Sokabe M.
Extracellular ATP-dependent activation of plasma membrane Ca2+ pump in HEK-293 cells.
Br J Pharmacol
131:
370-374,
2000
28.
Robey, RB,
Ruiz OS,
Baniqued J,
Mahmud D,
Espiritu DJ,
Bernardo AA,
and
Arruda JA.
SFKs, Ras, and the classic MAPK pathway couple muscarinic receptor activation to increased Na-HCO(3) cotransport activity in renal epithelial cells.
Am J Physiol Renal Physiol
280:
F844-F850,
2001
29.
Rohlicek, V,
and
Ullrich KJ.
Simple device for continuous measurement of fluorescent anions and cations in the rat kidney in situ.
Renal Physiol Biochem
17:
57-61,
1994[ISI][Medline].
30.
Ruiz, OS,
and
Arruda JA.
Regulation of the renal Na-HCO3 cotransporter by cAMP and Ca-dependent protein kinases.
Am J Physiol Renal Fluid Electrolyte Physiol
262:
F560-F565,
1992
31.
Schlatter, E,
Ankorina I,
Haxelmans S,
and
Kleta R.
Effects of diadenosine polyphosphates, ATP and angiotensin II on cytosolic Ca2+-activity and contraction of rat mesangial cells.
Pflügers Arch
430:
721-728,
1995[ISI][Medline].
32.
Stachon, A,
Hohage H,
Feidt C,
and
Schlatter E.
Characterization of organic cation transport across the apical membrane of proximal tubular cells with the fluorescent dye 4-Di-1-ASP.
Cell Physiol Biochem
7:
264-274,
1997[ISI].
33.
Stachon, A,
Schlatter E,
and
Hohage H.
Dynamic monitoring of organic cation transport processes by fluorescence measurements in LLC-PK1 cells.
Cell Physiol Biochem
6:
72-81,
1996[ISI].
34.
Sugawara-Yokoo, M,
Urakami Y,
Koyama H,
Fujikura K,
Masuda S,
Saito H,
Naruse T,
Inui K,
and
Takata K.
Differential localization of organic cation transporters rOCT1 and rOCT2 in the basolateral membrane of rat kidney proximal tubules.
Histochem Cell Biol
114:
175-180,
2000[ISI][Medline].
35.
Tamai, I,
Ohashi R,
Nezu J,
Yabuuchi H,
Oku A,
Shimane M,
Sai Y,
and
Tsuji A.
Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2.
J Biol Chem
273:
20378-20382,
1998
36.
Terashita, S,
Dresser A,
Zhang L,
Gray AT,
Yost SC,
and
Giacomelli K.
Molecular cloning and functional expression of a rabbit renal organic cation transporter.
Biochim Biophys Acta
1369:
1-6,
1998[ISI][Medline].
37.
Tong, JF,
Du GG,
Chen SRW,
and
MacLennan DH.
HEK-293 cells possess a carbachol- and thapsigargin-sensitive intracellular Ca2+ store that is responsive to stop-flow medium changes and insensitive to caffeine and ryanodine.
Biochem J
343:
39-44,
1999[ISI][Medline].
38.
Tsuruoka, S,
Sugimoto K,
Fujimura A,
Imai M,
Asano Y,
and
Muto S.
Protein kinase C and phosphatidylinositol 3-kinase independently contribute to P-glycoprotein-mediated drug secretion in the mouse proximal tubule.
Pflügers Arch
442:
321-328,
2001[ISI][Medline].
39.
Ullrich, KJ,
and
Rumrich G.
Luminal transport system for choline+ in relation to the other organic cation transport systems in the rat proximal tubule-kinetics, specificity: alkyl/arylamines, alkylamines with OH, O, SH, NH2, ROCO, RSCO and H2PO4-groups, methylaminostyryl, rhodamine, acridine, phenanthrene and cyanine compounds.
Pflügers Arch
432:
471-485,
1996[ISI][Medline].
40.
Urakami, Y,
Akazawa M,
Saito H,
Okuda M,
and
Inui KI.
cDNA cloning, functional characterization, and tissue distribution of an alternatively spliced variant of organic cation transporter hOCT2 predominantly expressed in the human kidney.
J Am Soc Nephrol
13:
1703-1710,
2002
41.
Weinman, E,
Hanley R,
Morell G,
Yuan N,
Steplock D,
Bui G,
and
Shenolikar S.
Regulation of the renal Na+-H+ exchanger by calcium calmodulin-dependent multifunctional protein kinase II.
Miner Electrol Metab
18:
35-39,
1992[ISI].
42.
Wright, SH,
and
Wunz TM.
Influence of substrate structure on substrate binding to the renal organic cation H+ exchanger.
Pflügers Arch
437:
603-610,
1999[ISI][Medline].
43.
Wu, X,
Prasad PD,
Leibach FH,
and
Ganapathy V.
cDNA sequence, transport function, and genomic organization of human OCTN2, a new member of the organic cation transporter family.
Biochem Biophys Res Commun
246:
589-595,
1998[ISI][Medline].
44.
Yamada, H,
Seki G,
Taniguchi S,
Uwatoko S,
Nosaka K,
Suzuki K,
and
Kurokawa K.
Roles of Ca2+ and PKC in regulation of acid/base transport in isolated proximal tubules.
Am J Physiol Renal Fluid Electrolyte Physiol
271:
F1068-F1076,
1996
45.
Zelikovic, I,
and
Przekwas J.
Ca2+-dependent protein kinases modulate proline transport across the renal brush-border membrane.
Am J Physiol Renal Fluid Electrolyte Physiol
268:
F155-F162,
1995
46.
Zhang, L,
Brett CM,
and
Giacomini KM.
Role of organic cation transporters in drug absorption and elimination.
Annu Rev Pharmacol Toxicol
38:
431-460,
1998[ISI][Medline].
47.
Zhang, L,
Dresser MJ,
Chun JK,
Babbitt PC,
and
Giacomini KM.
Cloning and functional characterization of a rat renal organic cation transport isoform (rOCT1A).
J Biol Chem
272:
16548-16554,
1997
48.
Zhang, L,
Dresser MJ,
Gray AT,
Yost SC,
Terashita S,
and
Giacomini KM.
Cloning and functional expression of a human liver organic cation transporter.
Mol Pharmacol
51:
913-921,
1997